Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Craig Jones

CNBC's Final Trades: CVS Health, AbbVie And This Travel Stock

On CNBC’s “Halftime Report Final Trades,” Joseph Terranova of Virtus Investment Partners recommended to sell CVS Health Corp (NYSE:CVS). Terranova said he had bought the stock on January 20 at $101 and “it’s gone nowhere.”

Bryn Talkington of Requisite Capital Management named AbbVie Inc (NYSE:ABBV) for those looking for stocks outside energy and commodity. “It’s done great this year. It’s got a really nice dividend of over 3.4%. I think it gives good diversification with strong technicals and fundamentals,” she added.

Check out other stocks to diversify your portfolio that are moving in the premarket.

Stephen Weiss of Short Hills Capital Partners named Delta Air Lines Inc (NYSE:DAL) as his pick. “Flying is back,” he added.

Also Read: CNBC's Final Trades: Canadian Natural Resources, Ericsson Telefon, Duke Energy And This Tech Stock

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.